Scientists scan to see why prostate cancer fights back
NCT ID NCT07302763
Summary
This study aims to understand why some tumors in a patient with advanced prostate cancer stop responding to treatment while others may still be controlled. Researchers will use a series of specialized PET scans on 45 participants to track individual tumors before, during, and after standard therapies. The goal is to learn how cancer evolves resistance, which could help doctors choose better treatments in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MCRPC (METASTATIC CASTRATION-RESISTANT PROSTATE CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Québec-Université Laval
RECRUITINGQuébec, Quebec, G1J1Z4, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.